MIZUHO SECURITIES USA LLC - 11 Feb 2025 Form 4 Insider Report for Aimei Health Technology Co., Ltd. (AFJK)

Reporting relationship: 10%+ Owner
Issuer ticker: AFJK
Reported as of: 11 Feb 2025
Net transaction value: -$1,629,000
SEC form: 4
Accepted by SEC: 11 Feb 2025, 14:52:51 UTC
Prior SEC filing: 11 Feb 2025
Next SEC filing: 15 Jul 2025
Source filing: View source filing
Reporting owner signature: Gregory Doig

Key filing fact

MIZUHO SECURITIES USA LLC filed Form 4 for Aimei Health Technology Co., Ltd. (AFJK) on 11 Feb 2025.

Key facts

This page summarizes MIZUHO SECURITIES USA LLC's Form 4 filing for Aimei Health Technology Co., Ltd. (AFJK).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Feb 2025, 14:52.

Change

Previous filing in this sequence was filed on 11 Feb 2025.
Current net transaction value: -$1,629,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AFJK transaction

Common Stock

Sale

Transaction value: $1,629,000
Shares: -150,000
Change %: -21%
Price: $10.86
Shares after: 550,387
Date: 11 Feb 2025
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

MIZUHO SECURITIES USA LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

SEC remarks

Subsidiary of parent. Mizuho Americas.